Moderna· @moderna_tx · X·· 2026-08-28AI 评分42
AI 导读
今日我们宣布，美国FDA已批准Spikevax®（COVID-19疫苗，mRNA）和mNEXSPIKE®（COVID-19疫苗，mRNA）2026-2027配方的补充生物制品许可申请，该配方含有SARS-CoV-2的JN.1谱系XFG亚变异株，用于帮助预防COVID-19。 阅读更多：https://feeds.issuerdirect.com/news-release.html?newsid=5391658462991287&symbol=MRNA
正文
Today we announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Applications for the 2026-2027 formulas for Spikevax® (COVID-19 Vaccine, mRNA) and mNEXSPIKE® (COVID-19 Vaccine, mRNA), containing the JN.1-lineage XFG subvariant of SARS-CoV-2 to help prevent COVID-19.
Read more: https://feeds.issuerdirect.com/news-release.html?newsid=5391658462991287&symbol=MRNA
来源：Moderna · x.com